HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics
- 1 August 2012
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 82 (3) , 338-343
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- APOL1 Variants Increase Risk for FSGS and HIVAN but Not IgA NephropathyJournal of the American Society of Nephrology, 2011
- APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated NephropathyJournal of the American Society of Nephrology, 2011
- Differential Effects of MYH9 and APOL1 Risk Variants on FRMD3 Association with Diabetic ESRD in African AmericansPLOS Genetics, 2011
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging miceJournal of Clinical Investigation, 2010
- Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expressionJournal of Clinical Investigation, 2009
- Apolipoprotein L1, a Novel Bcl-2 Homology Domain 3-only Lipid-binding Protein, Induces Autophagic Cell DeathJournal of Biological Chemistry, 2008
- Chronic Kidney Disease Incidence, and Progression to End‐Stage Renal Disease, in HIV‐Infected Individuals: A Tale of Two RacesThe Journal of Infectious Diseases, 2008
- Podocytes use FcRn to clear IgG from the glomerular basement membraneProceedings of the National Academy of Sciences, 2008